Toripalimab's expanded use in India brings real-world evidence into focus, with a multicentre study examining treatment outcomes across PD-L1 subgroups.
Cotecna, a leading provider of Testing, Inspection and Certification (TIC) services, today announced the acquisition of Energon Labs, a cGMP-compliant, USFDA-inspected, ISO 9001:2015 and ISO 17025:2017 certified analytical testing laboratory
Eosinophilic esophagitis treatment gains a potential new option as AstraZeneca and Amgen report sustained remission and symptom improvements with Tezspire.
GSK’s Hibsago becomes the first ASO approved for chronic hepatitis B, offering patients a new treatment approach for sustained viral control.
Sun Pharma’s $355M acquisition of Unloxcyt gains momentum as the therapy earns NCCN Category 2A status for locally advanced skin cancer.
Pharma giants pour billions into Chinese innovation, securing advanced oncology platforms, AI-powered clinical trials, and next-generation drug-delivery technologies.
Fake medicine billing allegations in Lucknow highlight gaps in pharmaceutical distribution, invoice verification, and drug traceability.
Bajaj Healthcare Q2 Results for FY27 show strong growth in revenue and profitability, supported by rising API exports and formulations sales.
India’s pharmaceutical sector is seeing major developments in drug pricing, cancer treatment, manufacturing, and international market expansion. The Centre has notified a 30 percent trade-margin cap on 137 anti-cancer drugs, while Lupin has...
Neovii Biotech and VINS Bioproducts plan immunoglobulin collaboration with technology transfer to India, potentially strengthening domestic biologics manufacturing and transplant care.